BioSpace News Archive

Cyclo Therapeutics Inc. Announces Positive Top Line Results from Phase I Trial and Interim Analysis of Phase I/II Trial using Trappsol ® Cyclo™ Intravenously to Treat Patients with Niemann-Pick Disease Type C1 (NPC1) Top line results of Phase I study confirm favorable safety and tolerability of Trappsol ® Cyclo™ in patients with NPC1 and demonstrate biological responses for both dose groups. An Unblinded Interim Analysis of Phase I/II study shows encourag

Case Study Published in JAMDA and Presented at AMDA Highlights How Early Warning Indications Allow Staff to Identify Acute Changes of Condition For Preventative Action [20-May-2020] WOBURN, Massachusetts , May 20, 2020 / PRNewswire/ -- EarlySense , the global leader in contact-free, continuous monitoring solutions for the healthcare continuum, announced tha

Publication Demonstrates Ability of Sera Prognostics’ PreTRM ® Biomarker Test as a Predictor of Adverse Pregnancy Outcomes - New data published in American Journal of Obstetrics & Gynecology Maternal Fetal Medicine further support potential use of PreTRM ® to identify pregnancies that may benefit from preterm birth preventive strategies -

BioLab Sciences , a regenerative biotechnology company, today announced a partnership with Red One Medical that will help veterans and active military members access breakthrough wound healing and regenerative medicine. Red One Medical is private sector innovation partner of Department of Veterans Affairs (VA) and Department of Defense (DoD) hospitals. As a Service-Disabled Veteran-Owned Small Business (SDVOSB), it provides

OpSens Inc. reached an important milestone with more than 100,000 patients evaluated with the OptoWire™, a pressure guidewire for the diagnosis and treatment of coronary artery stenosis.

Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to utilizing proprietary non-viral gene engineering platform technologies to create next generation cell and gene therapeutics with the capacity to cure, today announced the first patient has been dosed in its Phase 1 clinical trial evaluating P-PSMA-101, its au

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the launch of RADICAVA ® (edaravone) JourneyMate ™ , a new program connecting people with amyotrophic lateral sclerosis (ALS) and their families to live nurse educational support, which can help answer questions about the disease and treatment options.

As part of its ongoing work to advance potentially transformational medicines, GlaxoSmithKline plc will present new data at the upcoming 2020 American Society of Clinical Oncology (ASCO) Annual Meeting from 29-31 May 2020 .

Prevention efforts to combat the opioid crisis by limiting early exposure are working in the pediatric population, according to a study released as part of the American Academy of Orthopaedic Surgeons’ Virtual Education Experience.

Comet Bio announced today the successful completion of its randomized, placebo-controlled, crossover clinical trial evaluating the gastrointestinal (GI) tolerability and prebiotic effects of its Arabinoxylan Plant Fiber Extract, Arrabina™. Resu